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Abstract The structural integrity of the Golgi apparatus is
known to be dependent on multiple factors, including the orga-
nizational status of microtubules, actin and the ankyrin/spectrin-
based Golgi membrane skeleton, as well as vesicular tra⁄cking
and pH homeostasis. In this respect, our recently identi¢ed
Golgi-associated anion exchanger, AE2, may also be of impor-
tance, since it potentially acts as a Golgi pH regulator and as a
novel membrane anchor for the spectrin-based Golgi membrane
skeleton. Here, we show that inhibition (s 75%) of AE2 ex-
pression by antisense oligonucleotides in COS-7 cells results in
the fragmentation of the juxtanuclear Golgi apparatus and in
structural disorganization of the Golgi stacks, the cisternae be-
coming generally shorter, distorted, vesiculated and/or swollen.
These structural changes occurred without apparent dissociation
of the Golgi membrane skeletal protein Ankyrin195, but were
accompanied by the disappearance of the well-focused micro-
tubule-organizing center (MTOC), suggesting the involvement
of microtubule reorganization. Similar changes in Golgi struc-
ture and assembly of the MTOC were also observed upon tran-
sient overexpression of the EGFP-AE2 fusion protein. These
data implicate a clear structural role for the AE2 protein in
the Golgi and in its cytological positioning around the MTOC.
4 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The Golgi apparatus is a highly organized, dynamic organ-
elle that is specialized in the processing of newly synthesized
glycoproteins and -lipids, and in their delivery to the correct
intracellular or extracellular destinations. Over the last decade
major progress has been made in understanding the molecular
mechanisms that regulate Golgi architecture and cisternal
stacking, including vesicle tethering proteins (giantin, p115,
GM130, rab1, rab2), docking and fusion proteins (GOS28,
syntaxin5, NSF and SNAPS, p47, p97) and the stacking pro-
teins GRASP65 and GRASP55 [1^4]. The assembly/disassem-
bly cycles of the cisternae mediated by these proteins during
mitotic Golgi breakdown are regulated by phosphorylation
[5,6]. Other proteins/cytoskeletal elements that associate di-
rectly, or indirectly, with the above Golgi matrix (or exoskel-
etal) proteins include medial Golgi enzymes [7], members of
the p24 cargo receptor family [8], microtubules, associated
molecular motors, and the dynactin complex [9^13], as well
as actin [14,15], myosins [16,17], and the ankyrin/spectrin-
based Golgi membrane skeleton [18^22].
The Golgi membrane-associated membrane skeleton is
known to consist of at least two distinct ankyrin isoforms,
ANKG119 and ANK195, and one spectrin isoform, LIII-spec-
trin [23^26]. The exact role(s) of the Golgi membrane skeleton
is unclear, but it is thought either to provide a structural
sca¡old, or to form a novel vesicle coat complex [18^22].
Accordingly, spectrin is released from the Golgi membranes
either during mitotic Golgi breakdown, or by allowing brefel-
din A-mediated fusion of the Golgi membranes with the en-
doplasmic reticulum (ER). Overexpression of a homologous
LI-spectrin peptide has also been shown to impair ER-to-Gol-
gi transport of some membrane proteins, such as vesicular
stomatitis virus (VSV)-G protein and Na/K-adenosine tri-
phosphatase (ATPase) [27].
Previously, it has been reported that Golgi spectrin binds
directly to Golgi membrane lipids via its membrane associa-
tion domains (MADs). This binding is regulated by adenosine
diphosphate (ADP) ribosylation factor (ARF), independently
of its ability to stimulate COPI^coat formation [28]. Golgi
spectrin also interacts directly with both ANKG119 and
ANK195 [24,25], and with the Arp1 subunit of the dynactin
complex [29], suggesting additional interactions between spec-
trin and Golgi membranes (via ankyrin) or microtubules (via
the dynactin/dynein complex). One potential ankyrin-interact-
ing Golgi membrane protein is the anion exchanger 2 (AE2),
which we have previously identi¢ed in a number of cell types
[30,31]. In erythrocytes an analogous ankyrin/spectrin mesh-
work is known to associate with the plasma membrane AE1
(also termed Band 3), a founder member of the anion ex-
changer (AE) gene family. Studies with knockout mice [32]
have also demonstrated that this interaction is essential for
the maintenance of erythrocyte cell shape and mechanical
stability. The AE2 protein may thus serve a similar function
in Golgi membranes by providing a membrane anchorage site
for the underlying ankyrin/spectrin-based Golgi membrane
skeleton. Therefore, AE2 probably has an important role in
the maintenance of normal Golgi architecture in mammalian
cells, although no evidence supporting this possibility cur-
rently exists. Here we show that the AE2 protein is indeed
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required for the structural organization of the Golgi appara-
tus in COS-7 cells.
2. Materials and methods
2.1. Antibodies and plasmid constructs
A polyclonal antibody against the AE2 C-terminal peptide (amino
acids 1229^1241 of AE2) was a⁄nity puri¢ed as described earlier [31].
Monoclonal antibodies against GM130 and the KDEL receptor were
purchased from Transduction Laboratories (Lexington, KY, USA)
and Stressgen (Victoria, Canada) respectively. A monoclonal antibody
against K-tubulin was obtained from Sigma (St. Louis, MO, USA).
The anti-giantin monoclonal antibody was a kind gift from Dr. Hans-
Peter Hauri (Basel, Switzerland). Rabbit antisera against Ank195 and
AnkG119 were kindly donated to us by Dr. Kenneth Beck (University
of California, Davis, CA, USA) and Dr. Jon Morrow (Yale Univer-
sity, CT, USA), respectively. A monoclonal anti-green £uorescent
protein (GFP) antibody was purchased from Clontech (Palo Alto,
CA, USA). Alexa £uor-conjugated secondary antibodies were pur-
chased from Molecular Probes Inc. (Eugene, OR, USA) and peroxi-
Fig. 1. Inhibition of the expression of AE2 protein in the Golgi by antisense oligonucleotides in COS-7 cells. A: After antisense oligonucleotide
treatments, cells were double-stained with antibodies against AE2, giantin and the KDEL receptor (bars = 10 Wm). B: The staining intensities of
AE2 and Golgi markers were quanti¢ed using AnalySIS software (Soft Imaging System, USA). The intensity values (meanRS.D./400 Wm2 ;
n=60 cells/group) were obtained by subtracting the background values from the intensity values measured in selected Golgi regions. Note that
the expression of AE2 protein in the Golgi is inhibited by 77% in antisense oligonucleotide (AS)-treated cells, relative to control cells. C, con-
trol cells ; AS, antisense oligonucleotide-treated cells. C: Golgi fragmentation in AE2 depleted COS-7 cells. Maximal diameters of the Golgi ele-
ments (giantin) were measured in control cells (black circles, n=445) and in antisense oligonucleotide-treated cells (gray circles, n=445) using
the AnalySIS software. D: Correlation between AE2 expression and Golgi morphology. Cells were treated and stained as above. In the merged
¢gure, notice the fragmented Golgi elements (green) and the absence of AE2 protein (red). The yellow color denotes to cells that still have a
compact Golgi apparatus and express the AE2 protein (red, arrowheads). The staining intensities of AE2 protein and the maximal diameters of
the Golgi elements (giantin) were quantitated from 60 double-stained control or antisense oligonucleotide-treated cells and used for regression
analyses. Bars, 10 Wm. (For interpretation of the references to colour in this ¢gure legend, the reader is referred to the web version of this ar-
ticle.)
FEBS 28268 8-4-04 Cyaan Magenta Geel Zwart
K. Holappa et al./FEBS Letters 564 (2004) 97^10398
dase-conjugated secondary antibodies from PARIS (Compiegne,
France). Plasmid constructs (encoding EGFP- and DsRed-AE2 fusion
proteins) and cell transfections with the FUGENE 6 transfection re-
agent have been described previously [31].
2.2. Cell cultures and antisense oligonucleotide treatments
Phosphorothioate antisense oligonucleotides corresponding to the
translational initiation site of AE2 mRNA (5P-gcGCTGCTCATG-
GCCGAATCTtag-3P) were obtained from Cybergene (Huddinge,
Sweden). Several di¡erent thiol-modi¢ed oligonucleotide batches
were tested, of which the one possessing two modi¢ed bases at the
5P end and three bases at the 3P end (small letters) was most e¡ective
when applied directly onto cells.
COS-7 cells (ATCC, Rockville, MD, USA) were grown on Petri
dishes, or on glass coverslips, in Dulbecco’s modi¢ed Eagle’s medium
(DMEM)-high-glucose medium supplemented with Glutamax (Gibco,
Grand Island, NY, USA), 10% fetal calf serum (FCS) and penicillin^
streptomycin. Cells were plated 1 day before the addition of the anti-
sense oligonucleotides (25 Wg/ml serum-free medium). After 4^6 h, the
serum was added and the cells were cultivated for additional 2^3 days
without changing the medium.
2.3. Indirect immuno£uorescence
Cells were processed for indirect immuno£uorescence, as described
elsewhere [30]. Brie£y, cells were washed with phosphate-bu¡ered sa-
line (PBS), ¢xed with 3.7% formaldehyde in PBS and stained sequen-
tially with appropriate primary and secondary antibodies in the pres-
ence of 0.05% saponin. Stained specimens were examined using an
epi£uorescence microscope equipped with a CCD camera. AnalySIS
software (Soft Imaging System Corp., Lakewood, CO, USA) was used
for quanti¢cation.
2.4. Electron microscopy
Cells grown on plastic Petri dishes were rinsed twice with 0.1 M Na-
phosphate bu¡er (pH 7.4), ¢xed on plates with 2.5% glutaraldehyde
for 2 h at room temperature and post-¢xed on plates in 1% osmium
tetroxide before dehydration and embedding in ethanol-epon LX112,
and ¢nally with epon only. Thin sections were cut and post-stained
with uranyl acetate and lead citrate before examination. Peroxidase
staining, when applicable, was performed on p-formaldehyde (p-FA,
4%) ¢xed cells before embedding. Saponin was used as permeabilizing
agent. Labeling of cells with protein A-coated gold particles (5 and 10
nm) has been described elsewhere [33]. Brie£y, cells were ¢xed with
4% p-FA in PBS, scraped from the culture plates, embedded in 4%
gelatin and snap frozen in liquid nitrogen in the presence of 2.3 M
saccharose before cutting thin sections (80^100 nm) and immunostain-
ing of the sections with appropriate primary antibodies, secondary
rabbit anti-mouse antibodies and ¢nally with colloidal gold coated
with protein A.
3. Results
3.1. Inhibition of AE2 expression by antisense oligonucleotides
To assess the structural role of AE2 protein in the Golgi we
utilized AE2a isoform-speci¢c antisense oligonucleotides and
COS-7 cells, as these cells possess a highly compact and jux-
tanuclear Golgi apparatus, respond well to antisense oligonu-
cleotides and exhibit a strong labeling for AE2 protein [31].
We found that AE2-speci¢c antisense oligonucleotides signi¢-
cantly reduced the expression of AE2 protein in the Golgi
(Fig. 1A). Based on the measured relative £uorescence inten-
sities (Fig. 1B), the expression level of AE2 protein was re-
duced by 77% from that found in control cells. This inhibition
was speci¢c to AE2 protein, as the expression levels of the
Golgi marker proteins, giantin and the KDEL receptor (Fig.
1A,B), remained practically unchanged. Furthermore, non-
sense oligonucleotides, or di¡erentially thiol-modi¢ed AE2
antisense oligonucleotides, did not markedly inhibit the ex-
pression of the AE2 protein under identical conditions (data
not shown).
3.2. Golgi morphology is altered in AE2 depleted cells
In contrast to control cells, the Golgi morphology in AE2
cells was markedly altered, as assessed by staining the cells
with the two Golgi marker antibodies. Speci¢cally, the Golgi
was fragmented and scattered into the perinuclear region in
Fig. 2. Electron microscopy of Golgi stacks in AE2 depleted cells. Cells were grown on plastic culture plates and treated, or not, with antisense
oligonucleotides. After ¢xation cells were processed for conventional transmission electron microscopy. Note that in control cells (left) the Golgi
stacks (arrows) are well organized and consist of tightly packed and £attened cisternae. In antisense oligonucleotide-treated cells, the Golgi
stacks of cisternae show pleiomorphic structural changes (A^D; arrowheads), including fenestrated (A), swollen (B), vesiculated (C) or distorted
(D) cisternae. Bar 200 nm (m, mitochondria; n, nucleus).
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AE2 depleted cells (Fig. 1A). To allow quantitative estimates
we measured the maximal distance between the scattered Gol-
gi elements in each cell (n=445 cells/group). We found that
the average maximal diameter (Fig. 1C) of the Golgi elements
in control cells was 5.9 Wm (R 1.9 Wm, S.D.), whereas it was
13.8 Wm (R 5.5 Wm, S.D.) in AE2 depleted cells (Fig. 1C; gray
circles). Thus, the maximal distance between the fragmented
Golgi elements was more than doubled, relative to control
cells.
Double-staining experiments with anti-AE2 and anti-gian-
tin antibodies showed that AE2 depleted cells, particularly
those that possessed a compact Golgi apparatus, still ex-
pressed AE2 protein at a considerable level (Fig. 1D), suggest-
ing that these two parameters may correlate with each other.
Regression analyses revealed that AE2 expression and frag-
mented Golgi structure do correlate inversely to some extent
(with a correlation coe⁄cient of 30.60). Taken together the
results implicate an important role for AE2 protein in the
maintenance of a compact and juxtanuclear Golgi apparatus
in COS-7 cells.
Electron microscopy was utilized to assess whether AE2
depletion perturbed the morphology of the Golgi stacks. In
control cells over 90% of the Golgi stacks were well organized
and typically consisted of few £attened and stacked cisternae
with adjacent transport vesicles (Fig. 2, left). However, in AE2
depleted cells (Fig. 2A^D), pleiomorphic structural changes in
the Golgi stacks of cisternae were observed. The stacks them-
selves were more dispersed and smaller in size than those
found in control cells and the individual cisternae often
showed fenestrations (Fig. 2A), were swollen (Fig. 2B) or
distorted (Fig. 2C,D) with or without adjacent cytoplasmic
vesicles. None of the AE2 depleted cells examined (out of
50 sections) was found to contain structurally normal Golgi
stacks. Thus, AE2 protein seems to be required also for the
structural organization of the Golgi stacks of cisternae.
3.3. Ank195 remains associated with the Golgi membranes in
AE2 depleted cells
Previous studies have shown that both Ank195 [25] and AE2
([30,34], our unpublished data), localize predominantly to the
trans-side of the Golgi stack, are resistant to Triton X-100
extraction and also co-redistribute upon overexpression of a
EGFP-AE2 fusion protein in COS-7 cells. This suggests that
the two proteins may interact directly with each other, thereby
linking Golgi membranes to the underlying spectrin-based
Golgi membrane skeleton. To evaluate whether the observed
Golgi fragmentation in the absence of AE2 protein could
result from the dissociation of Ank195 from the Golgi mem-
Fig. 3. Association of Ank195 with the Golgi membranes. Control
and antisense oligonucleotide-treated cells were ¢rst detergent ex-
tracted, washed, ¢xed and double-stained with anti-GM130 (green)
and anti-ankyrin195 (red) antibodies. Note the presence and appar-
ent colocalization of the ANK195 (red) with the Golgi marker
(green) in both untreated and treated cells. Note also that the nuclei
(stars) are stained with the anti-Ank195 antibody in detergent-ex-
tracted cells. This is probably due either to non-speci¢c staining or
the existence of as yet unknown nucleus/ER-associated ankyrin iso-
form(s). Bar 10 Wm. (For interpretation of the references to colour
in this ¢gure legend, the reader is referred to the web version of
this article.)
Fig. 4. Disorganization of the MTOC in antisense oligonucleotide-
treated cells. COS-7 cells treated, or not, with the antisense oligonu-
cleotides were ¢xed and stained with anti-AE2 or anti K-tubulin
antibodies. In AE2 depleted cells, the MTOC is virtually absent and
microtubules appear to nucleate from multiple points around the
nuclear envelope (arrowheads). The insert in the middle is shown as
a higher magni¢cation at the bottom. Bars, 10 Wm.
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branes, we stained control and AE2 depleted cells with anti-
bodies against ANK195. Prior to staining, cells were extracted
with Triton X-100 to remove detergent-soluble ankyrin iso-
forms that are known to react with this anti-Ank195 polyclon-
al antibody [25]. We found equal levels of Ank195 in both
control and AE2 depleted cells (Fig. 3) and that Ank195 re-
mained in close association with the Golgi membranes despite
the apparent absence of AE2 protein. Other Golgi membrane
skeletal proteins (AnkG119, spectrin) are more widely distrib-
uted in COS-7 cells and only partially colocalize with the
Golgi markers (data not shown), and therefore are not useful
for these studies.
3.4. The microtubule network is disorganized in AE2 depleted
cells
Because Golgi morphology is known to depend on intact
microtubules [9,10], we next examined whether microtubule
organization was disrupted in AE2 depleted cells. We stained
both control and AE2 depleted cells with an anti-K-tubulin
antibody (Fig. 4) and found that in contrast to a well-orga-
nized microtubule network and a focused microtubule-organ-
izing center (MTOC) detected in control cells, the microtubule
network was disorganized in AE2 depleted cells (Fig. 4). The
cells also lacked a well-focused MTOC and microtubules ap-
peared to emanate from multiple points along the nuclear
envelope (Fig. 4, bottom). Thus, Golgi fragmentation induced
by AE2 depletion is accompanied by changes in the assembly
of the microtubule network and the MTOC.
3.5. Overexpression of EGFP-AE2 fusion protein also
interferes with Golgi structure
To provide additional evidence for a structural role of AE2
protein in Golgi membranes, we transiently overexpressed an
EGFP-tagged version of the AE2 protein in COS-7 cells. Sim-
ilarly to AE2 depletion, we found that overexpression of AE2
fusion protein (Fig. 5A) caused a marked fragmentation/vesic-
ulation of the Golgi, as assessed by staining the cells with the
anti-GM130 Golgi marker antibody (Fig. 5B). In neighboring
non-transfected cells, or in cells that expressed the fusion pro-
tein at a low but detectable level (data not shown), the Golgi
apparatus remained practically unaltered and juxtanuclear.
Similarly, Golgi structure was also preserved when the cells
were transfected with a truncated version of the AE2 protein
(Fig. 5C) that lacked the ¢rst 563 N-terminal amino acids,
6
Fig. 5. Overexpression of the EGFP-tagged AE2 fusion protein in-
duces accumulation of membranous aggregates in COS-7 cells. Cells
were transfected with EGFP-AE2 (A^B) or an N-terminally trun-
cated AE2 (C) encoding plasmid before ¢xation for indirect immu-
no£uorescence (A^C), or for electron microscopy (D,E). Double-
staining of the transfected cells (A) with the anti-GM130 antibody
(B) shows that the Golgi apparatus is fragmented in cells that ex-
press the fusion protein at high levels. In neighboring non-express-
ing cells (arrowheads) or in cells expressing the N-terminally trun-
cated AE2 variant (C), the Golgi apparatus remains compact and
juxtanuclear. Similar results were obtained with DsRed-AE2 protein
(data not shown). D: Electron micrograph of the peroxidase-stained
EGFP-AE2 protein in transfected cells. Note the accumulation of
large tubular or lamellar membrane aggregates near the nuclei (n).
E: Double immunogold labeling of the membrane aggregates with
anti-GFP (5 nm gold) and anti-KDEL receptor antibodies (10 nm
gold, black arrowheads). Note the coexistence of the two proteins
within the membranous aggregates. Bars (A,B) 10 Wm; (C,D) 200
nm.
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including the potential ankyrin binding domain of the AE2
protein. Ankyrin interaction(s) thus appears to be crucial for
the ability of overexpressed AE2 protein to cause structural
disorganization of the Golgi.
Electron microscopy with an anti-GFP antibody demon-
strated further that overexpression of the full length AE2
fusion protein induced the accumulation of large, intercon-
nected and tightly packed lamellar or tubular membranes in
the transfected cells (Fig. 5D). Accumulation of these ‘mem-
branous aggregates’ was also accompanied by the virtual lack
of any morphologically identi¢able Golgi stacks. That these
membranous aggregates represent at least partly Golgi mem-
branes was demonstrated by double-staining with antibodies
against the KDEL receptor and giantin, both of which deco-
rated these EGFP-rich membranous structures (Fig. 5E). In
addition, protein disul¢de isomerase (PDI), a luminal ER
protein, was not present in these structures (data not shown).
Overexpression of the EGFP-AE2 fusion protein, similarly
to AE2 depletion, was also accompanied by changes in the
organization of the microtubule network and the MTOC.
Although equivalent amounts of polymerized microtubules
were detected both in non-transfected and transfected cells
(Fig. 6), it was found that the well-focused MTOC seen in
control cells was virtually absent in cells that expressed the
fusion protein. Microtubules also appeared to radiate, simi-
larly to AE2 depleted cells, from multiple points along the
nuclear envelope, often forming randomly oriented arrays in
the cell periphery. Similar results were also obtained with a
DsRed-AE2 fusion protein (data not shown). Thus, similarly
to AE2 depletion, overexpression of the EGFP-tagged AE2
protein interferes with the normal organization of the Golgi
and the MTOC.
4. Discussion
In this work we have exploited both antisense oligonucleo-
tide-mediated depletion and overexpression to assess the
structural role of AE2 protein in the Golgi apparatus in
COS-7 cells. Both approaches were found to induce marked
alterations in the overall Golgi structure, organization of the
polarized Golgi stacks and the MTOC. We also showed that
these alterations required the presence of putative ankyrin
interaction domain(s), as a truncated version of the AE2 pro-
tein lacking these (but containing the ion transport domain)
did not markedly a¡ect Golgi morphology. This ¢nding
makes it highly unlikely that the disorganization of the Golgi
results simply from non-speci¢c interactions due to overex-
pression of any polytopic membrane protein. The possibility
that these structural changes re£ect a mere accumulation of
mitotic or apoptotic cells with fragmented Golgi elements was
also excluded on the basis that the cells contain polymerized
microtubules and intact nuclei. Thus, our data implicate a role
for the AE2 protein in the maintenance of normal Golgi
structure and in the assembly of a well-focused MTOC.
Our data are consistent with the suggested membrane-sta-
bilizing and/or transport-facilitating roles of the ankyrin/spec-
trin-based Golgi membrane skeleton [21,22], and with AE2
protein being an important part of this multiprotein sca¡old.
Although we have not been able to formally proof this yet
(due to lack of immunoprecipitating antibodies and Ank195
cDNA), there are several lines of indirect evidence to support
this view. For example, both the AE2 protein and Ank195 are
detergent resistant ([25,30], see also Fig. 3), colocalize in the
trans-Golgi and co-redistribute upon overexpression of the
anion exchanger [34]. Moreover, by analogy to severe endo-
vesiculation of erythrocytes despite the apparently unaltered
ankyrin^spectrin membrane skeleton in AE1 knockout mice
[32], we observed that the Golgi stacks had a more vesiculated
appearance in AE2 depleted cells than those found in control
cells (Fig. 2), and that in our case, vesiculation also did not
require dissociation of Ank195 (and perhaps also of other
Golgi membrane skeletal components) into the cytoplasm
(Fig. 3). One possible explanation for this is that even in
the absence of AE2 protein, Ank195 remains in a detergent-
resistant pool together with other Golgi membrane skeletal
and Golgi matrix proteins, or is held near Golgi membranes
via its binding to spectrin and the known interactions of spec-
trin with Golgi membrane lipids. These observations, together
with the accumulation of large membranous ‘aggregates’ in
AE2 overexpressing cells, suggest that one role for AE2 pro-
tein is to provide additional stability to Golgi membranes by
linking the underlying membrane skeleton more ¢rmly to cel-
lular membranes. Consistent with this, Siddhanta et al. [35]
have shown that reduced spectrin binding to Golgi mem-
branes in the absence of phosphatidylinositol-4,5-bisphos-
phate synthesis also results in fragmentation of the Golgi.
Although the exact molecular details remain to be clari¢ed,
an impaired interplay between these proteins and Golgi mem-
branes in AE2 depleted cells could also interfere normal ve-
sicular tra⁄cking or routing along microtubules, with the re-
sult that the Golgi and the MTOC become disorganized.
Consistent with this, spectrin has been shown to associate
with the Arp1 subunit of the dynactin complex, which also
includes p150Glued, dynamitin (p50) and p62 [29]. The spec-
trin^dynactin complex in turn associates with the cytoplasmic
motor protein dynein, a microtubule minus end directed mo-
tor protein. Interestingly, overexpression of a spectrin peptide
encompassing the actin binding and the MADs (lipid binding
domains) has been reported to impair ER-to-Golgi transport
of certain membrane proteins [27,28], and up to half of the
cells that overexpress the dynamitin p50 subunit exhibit a
fragmented Golgi and a less focused MTOC due to the dis-
ruption of the dynactin complex [12]. In addition, Ma et al.
[36] have reported that overexpressed and mutated dynein
Fig. 6. Disassembly of the MTOC in AE2 overexpressing cells. Cells
were transfected with a plasmid encoding EGFP-AE2 before ¢xa-
tion and staining with the anti-K-tubulin antibody. Note the distinct
MTOCs in control (non-expressing) cells (A) and the apparent lack
of an MTOC in an AE2 overexpressing cell (B, white arrows). Bar
10 Wm.
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intermediate chain also induces Golgi fragmentation and dis-
organization of interphase microtubules by perturbing the dy-
nactin^dynein interaction. Collectively, these ¢ndings suggest
that interfering with any of the above protein^protein inter-
actions that appear to be involved in the binding of Golgi
membranes to microtubules, is likely to cause organizational
changes in the Golgi and the microtubule network. Based on
the above scenario, it is likely that in AE2 depleted cells the
structural disorganization of the Golgi and MTOC also re-
sults from an impaired association of Golgi membranes with
Golgi membrane skeletal proteins.
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